Your browser doesn't support javascript.
loading
Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception.
Medford, Arielle J; Moy, Beverly; Spring, Laura M; Hurvitz, Sara A; Turner, Nicholas C; Bardia, Aditya.
Afiliação
  • Medford AJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Moy B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Spring LM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Hurvitz SA; University of California Los Angeles, David Geffen School of Medicine, Los Angeles, California.
  • Turner NC; The Royal Marsden NHS Foundation Trust, Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
Clin Cancer Res ; 29(22): 4540-4548, 2023 11 14.
Article em En | MEDLINE | ID: mdl-37477704
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / DNA Tumoral Circulante Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / DNA Tumoral Circulante Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Ano de publicação: 2023 Tipo de documento: Article